Oragenics Inc. Stock
Your prediction
Pros and Cons of Oragenics Inc. in the next few years
Pros
?
S********** s********
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oragenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oragenics Inc. | - | - | - | - | - | - | - |
| Solasia Pharma KK | -1.910% | -6.548% | -10.795% | -10.795% | 18.045% | -45.486% | -84.904% |
| Northwest Biotherapeutics Inc. | -2.780% | 9.756% | 0.000% | -30.769% | -12.621% | -60.352% | -85.366% |
| Larimar Therapeutics Inc. | -4.090% | -10.938% | -16.176% | 30.534% | 3.012% | -16.585% | -69.464% |
Comments
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat